- Home
- MYNZ vs GIPR Comparison
MYNZ vs GIPR Comparison
Compare MYNZ & GIPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYNZ
- GIPR
- Stock Information
- Founded
- MYNZ 2021
- GIPR 2015
- Country
- MYNZ Germany
- GIPR United States
- Employees
- MYNZ N/A
- GIPR N/A
- Industry
- MYNZ Biotechnology: Pharmaceutical Preparations
- GIPR Real Estate Investment Trusts
- Sector
- MYNZ Health Care
- GIPR Real Estate
- Exchange
- MYNZ Nasdaq
- GIPR Nasdaq
- Market Cap
- MYNZ 10.5M
- GIPR 8.8M
- IPO Year
- MYNZ 2021
- GIPR 2021
- Fundamental
- Price
- MYNZ $3.44
- GIPR $1.64
- Analyst Decision
- MYNZ Buy
- GIPR Hold
- Analyst Count
- MYNZ 3
- GIPR 1
- Target Price
- MYNZ $14.00
- GIPR N/A
- AVG Volume (30 Days)
- MYNZ 177.3K
- GIPR 13.9K
- Earning Date
- MYNZ 04-15-2025
- GIPR 05-19-2025
- Dividend Yield
- MYNZ N/A
- GIPR 7.13%
- EPS Growth
- MYNZ N/A
- GIPR N/A
- EPS
- MYNZ N/A
- GIPR N/A
- Revenue
- MYNZ $893,991.00
- GIPR $9,762,636.00
- Revenue This Year
- MYNZ $20.94
- GIPR $26.85
- Revenue Next Year
- MYNZ $18.01
- GIPR $1.14
- P/E Ratio
- MYNZ N/A
- GIPR N/A
- Revenue Growth
- MYNZ N/A
- GIPR 27.91
- 52 Week Low
- MYNZ $0.18
- GIPR $1.50
- 52 Week High
- MYNZ $8.20
- GIPR $4.64
- Technical
- Relative Strength Index (RSI)
- MYNZ 37.70
- GIPR 50.62
- Support Level
- MYNZ $2.72
- GIPR $1.52
- Resistance Level
- MYNZ $5.34
- GIPR $1.63
- Average True Range (ATR)
- MYNZ 0.55
- GIPR 0.07
- MACD
- MYNZ -0.12
- GIPR 0.01
- Stochastic Oscillator
- MYNZ 27.48
- GIPR 66.67
About MYNZ Mainz Biomed N.V.
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples.
About GIPR Generation Income Properties Inc.
Generation Income Properties Inc is an internally managed real estate investment company focused on acquiring and managing income-producing retail, office and industrial properties net leased to high-quality tenants in major markets throughout the United States. Its key source of revenue is the rental income. The company holds properties in Alabama, Arizona, Colorado, the District of Columbia, Florida, Illinois, North Carolina and Virginia.